117 related articles for article (PubMed ID: 23109556)
1. Altered levels of homocysteine and serum natural antioxidants links oxidative damage to Alzheimer's disease.
Cankurtaran M; Yesil Y; Kuyumcu ME; Oztürk ZA; Yavuz BB; Halil M; Ulger Z; Cankurtaran ES; Arıoğul S
J Alzheimers Dis; 2013; 33(4):1051-8. PubMed ID: 23109556
[TBL] [Abstract][Full Text] [Related]
2. The association between homocysteine (hcy) and serum natural antioxidants in elderly bone mineral densitometry (BMD).
Kuyumcu ME; Yesil Y; Oztürk ZA; Cınar E; Kızılarslanoglu C; Halil M; Ulger Z; Yesil NK; Cankurtaran M; Arıoğul S
Arch Gerontol Geriatr; 2012; 55(3):739-43. PubMed ID: 22682423
[TBL] [Abstract][Full Text] [Related]
3. Relationship of cognitive function with B vitamin status, homocysteine, and tissue factor pathway inhibitor in cognitively impaired elderly: a cross-sectional survey.
Kim G; Kim H; Kim KN; Son JI; Kim SY; Tamura T; Chang N
J Alzheimers Dis; 2013; 33(3):853-62. PubMed ID: 23042212
[TBL] [Abstract][Full Text] [Related]
4. Alzheimer's disease treated patients showed different patterns for oxidative stress and inflammation markers.
Gubandru M; Margina D; Tsitsimpikou C; Goutzourelas N; Tsarouhas K; Ilie M; Tsatsakis AM; Kouretas D
Food Chem Toxicol; 2013 Nov; 61():209-14. PubMed ID: 23871825
[TBL] [Abstract][Full Text] [Related]
5. Effect of an antioxidant drink on homocysteine levels in Alzheimer's patients.
Morillas-Ruiz JM; Rubio-Perez JM; Albaladejo MD; Zafrilla P; Parra S; Vidal-Guevara ML
J Neurol Sci; 2010 Dec; 299(1-2):175-8. PubMed ID: 20850133
[TBL] [Abstract][Full Text] [Related]
6. Increased tissue factor pathway inhibitor and homocysteine in Alzheimer's disease.
Piazza F; Galimberti G; Conti E; Isella V; Perlangeli MV; Speranza T; Borroni B; Pogliani EM; Padovani A; Ferrarese C
Neurobiol Aging; 2012 Feb; 33(2):226-33. PubMed ID: 20359777
[TBL] [Abstract][Full Text] [Related]
7. Decreased plasma antioxidants in patients with Alzheimer's disease.
Kim TS; Pae CU; Yoon SJ; Jang WY; Lee NJ; Kim JJ; Lee SJ; Lee C; Paik IH; Lee CU
Int J Geriatr Psychiatry; 2006 Apr; 21(4):344-8. PubMed ID: 16534775
[TBL] [Abstract][Full Text] [Related]
8. The relation between homocysteine levels and development of Alzheimer's disease in mild cognitive impairment patients.
Annerbo S; Wahlund LO; Lökk J
Dement Geriatr Cogn Disord; 2005; 20(4):209-14. PubMed ID: 16088136
[TBL] [Abstract][Full Text] [Related]
9. Ischemia modified albumin and plasma oxidative stress markers in Alzheimer's disease.
Can M; Varlibas F; Guven B; Akhan O; Yuksel GA
Eur Neurol; 2013; 69(6):377-80. PubMed ID: 23751563
[TBL] [Abstract][Full Text] [Related]
10. Oxidative balance, homocysteine, and uric acid levels in older patients with Late Onset Alzheimer's Disease or Vascular Dementia.
Cervellati C; Romani A; Seripa D; Cremonini E; Bosi C; Magon S; Passaro A; Bergamini CM; Pilotto A; Zuliani G
J Neurol Sci; 2014 Feb; 337(1-2):156-61. PubMed ID: 24321755
[TBL] [Abstract][Full Text] [Related]
11. Plasma aminothiol compounds, but not serum tumor necrosis factor receptor II and soluble receptor for advanced glycation end products, are related to the cognitive impairment in Alzheimer's disease and mild cognitive impairment patients.
Hernanz A; De la Fuente M; Navarro M; Frank A
Neuroimmunomodulation; 2007; 14(3-4):163-7. PubMed ID: 18073509
[TBL] [Abstract][Full Text] [Related]
12. [Plasma levels of endogenous hydrogen sulfide and homocysteine in patients with Alzheimer's disease and vascular dementia and the significance thereof].
Liu XQ; Liu XQ; Jiang P; Huang H; Yan Y
Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(32):2246-9. PubMed ID: 19087670
[TBL] [Abstract][Full Text] [Related]
13. Homocysteine as a predictor of cognitive decline in Alzheimer's disease.
Oulhaj A; Refsum H; Beaumont H; Williams J; King E; Jacoby R; Smith AD
Int J Geriatr Psychiatry; 2010 Jan; 25(1):82-90. PubMed ID: 19484711
[TBL] [Abstract][Full Text] [Related]
14. Relations between homocysteine, folate and vitamin B12 in vascular dementia and in Alzheimer disease.
Köseoglu E; Karaman Y
Clin Biochem; 2007 Aug; 40(12):859-63. PubMed ID: 17532313
[TBL] [Abstract][Full Text] [Related]
15. Relation between uric acid and Alzheimer's disease in elderly Jordanians.
Al-khateeb E; Althaher A; Al-khateeb M; Al-Musawi H; Azzouqah O; Al-Shweiki S; Shafagoj Y
J Alzheimers Dis; 2015; 44(3):859-65. PubMed ID: 25362039
[TBL] [Abstract][Full Text] [Related]
16. Plasma levels of antioxidants are not associated with Alzheimer's disease or cognitive decline.
Engelhart MJ; Ruitenberg A; Meijer J; Kiliaan A; van Swieten JC; Hofman A; Witteman JC; Breteler MM
Dement Geriatr Cogn Disord; 2005; 19(2-3):134-9. PubMed ID: 15627760
[TBL] [Abstract][Full Text] [Related]
17. Pro-inflammatory cytokines IL-1β and TNF-α are not associated with plasma homocysteine concentration in Alzheimer's disease.
Veryard L; Jones E; Weaving G; Smith E; Cheek L; Wickramasinghe A; Tabet N
Curr Alzheimer Res; 2013 Feb; 10(2):174-9. PubMed ID: 23463936
[TBL] [Abstract][Full Text] [Related]
18. [Influence of vascular comorbidities on the antioxidant defense system in Alzheimer's disease].
Polidori MC; Stahl W; De Spirt S; Pientka L
Dtsch Med Wochenschr; 2012 Feb; 137(7):305-8. PubMed ID: 22318842
[TBL] [Abstract][Full Text] [Related]
19. Oxidative Stress Markers and Metal Ions are Correlated With Cognitive Function in Alzheimer's Disease.
Pu Z; Xu W; Lin Y; He J; Huang M
Am J Alzheimers Dis Other Demen; 2017 Sep; 32(6):353-359. PubMed ID: 28554217
[TBL] [Abstract][Full Text] [Related]
20. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
